Press Releases

	Cardax Awarded Important U.S. Patents December 17, 2009
	NIH Grant Funds Development of Cardax Liver Drug October 8, 2009
	Cardax Nominates Clinical Candidate Heptax for Liver Disease July 20, 2009
	Cardax Appoints Gil Rishton, Ph.D., Chief Science Officer May 25, 2009
	Cardax Co-founder Dr. Samuel F. Lockwood Moves to Private Firm April 9, 2007
	Leading Cardiovascular Experts Gather for Cardax SAB in Honolulu February 15, 2007
	A New Study Finds Astaxanthin is a Potent Inhibitor of Oxidation in Cell Membrane Model January 4, 2007
	Cardax Pharmaceuticals signs joint development and supply agreement with BASF December 4, 2006
	Dr. Fredric J. Pashkow Named Cardax Pharmaceuticals Chief Medical Officer, EVP October 8, 2006